Hu Y, Mangan J A, Dhillon J, Sole K M, Mitchison D A, Butcher P D, Coates A R
Department of Medical Microbiology, St. George's Hospital Medical School, London SW17 0RE, United Kingdom.
J Bacteriol. 2000 Nov;182(22):6358-65. doi: 10.1128/JB.182.22.6358-6365.2000.
Mycobacterium tuberculosis can persist in an altered physiological state for many years after initial infection, and it may reactivate to cause active disease. An analogous persistent state, possibly consisting of several different subpopulations of bacteria, may arise during chemotherapy; this state is thought to be responsible for the prolonged period required for effective chemotherapy. Using two models of drug-induced persistence, we show that both microaerophilic stationary-phase M. tuberculosis treated with a high dose of rifampin in vitro and pyrazinamide-induced persistent bacteria in mice are nonculturable yet still contain 16S rRNA and mRNA transcripts. Also, the in vitro persistent, plate culture-negative bacteria incorporate radioactive uridine into their RNA in the presence of rifampin and can rapidly up-regulate gene transcription after the replacement of the drug with fresh medium and in response to heat shock. Our results show that persistent M. tuberculosis has transcriptional activity. This finding provides a molecular basis for the rational design of drugs targeted at persistent bacteria.
结核分枝杆菌在初次感染后可在改变的生理状态下持续存在多年,并可能重新激活导致活动性疾病。在化疗期间可能会出现类似的持续状态,可能由几种不同的细菌亚群组成;这种状态被认为是有效化疗所需时间延长的原因。使用两种药物诱导持续性的模型,我们表明,体外经高剂量利福平处理的微需氧静止期结核分枝杆菌和小鼠体内吡嗪酰胺诱导的持续性细菌均不可培养,但仍含有16S rRNA和mRNA转录本。此外,体外持续性、平板培养阴性的细菌在利福平存在的情况下将放射性尿苷掺入其RNA中,在用新鲜培养基替换药物后并响应热休克时可迅速上调基因转录。我们的结果表明,持续性结核分枝杆菌具有转录活性。这一发现为针对持续性细菌的药物合理设计提供分子基础。